Goldman Sachs Downgrades Impax Laboratories To Neutral By: Benzinga via Benzinga February 11, 2015 at 08:06 AM EST Analysts at Goldman Sachs downgraded Impax Laboratories Inc. (NASDAQ: IPXL) from Buy to Neutral. The price target for Impax ... Read More >>